• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23371 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2012     National Institute for Health and Care Excellence (NICE) Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism. NICE technology appraisal guidance 261
2012     National Institute for Health and Care Excellence (NICE) Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M. NICE diagnostics guidance 6
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) AmniSure versus fern testing to assess the rupture of fetal membranes in pregnant women: a review of the comparative accuracy, cost-effectiveness, and guidelines
2012     NIHR Horizon Scanning Centre (NIHR HSC) Velimogene aliplasmid (Allovectin) for advanced or metastatic malignant melanoma
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Trametinib for advanced or metastatic BRAF V600E mutation-positive melanoma
2012     Agency for Healthcare Research and Quality (AHRQ) Treatment for restless legs syndrome
2012     National Institute for Health and Care Excellence (NICE) Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer. NICE technology appraisal guidance 263
2012     National Institute for Health and Care Excellence (NICE) SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver. NICE diagnostics guidance 5
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Procedure site bleeding complications following percutaneous coronary interventions or angioplasty: a review of clinical evidence and guidelines
2012     NIHR Horizon Scanning Centre (NIHR HSC) Vinflunine (Javlor) monotherapy for advanced breast cancer
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Avastin® for age-related macular degeneration]
2012     Agency for Healthcare Research and Quality (AHRQ) Strategies to reduce cesarean birth in low-risk women
2012     National Institute for Health and Care Excellence (NICE) Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours. NICE technology appraisal guidance 265
2012     National Institute for Health and Care Excellence (NICE) Laparoscopic gastric plication for the treatment of severe obesity. NICE interventional procedures guidance 432
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Codeine and acetaminophen for pain relief: a review of the clinical efficacy and safety
2012     NIHR Horizon Scanning Centre (NIHR HSC) Cangrelor to reduce platelet aggregation and thrombosis in patients undergoing percutaneous coronary intervention
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) IFEDH - Innovative Framework for Evidence Based Decision Making in Health Care: Standards on how to parameterise models via published literature: Input of the LBI-HTA (WP 4.2)
2012     Agency for Healthcare Research and Quality (AHRQ) Comparison of characteristics of nursing homes and other residential long-term care settings for people with dementia
2012     National Institute for Health and Care Excellence (NICE) Mannitol dry powder for inhalation for treating cystic fibrosis. NICE technology appraisal guidance 266
2012     National Institute for Health and Care Excellence (NICE) Percutaneous laser atherectomy as an adjunct to balloon angioplasty (with or without stenting) for peripheral arterial disease. NICE interventional procedures guidance 433
2012     The Swedish Council on Health Technology Assessment (SBU) [Blood test for early diagnosis of Alzheimer's disease]
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Point-of-care testing: a review of systematic reviews on testing accuracy and cost-effectiveness
2012     NIHR Horizon Scanning Centre (NIHR HSC) SAR236553/REGN727 for the reduction of elevated total cholesterol and low density lipoprotein cholesterol
2012     Agency for Healthcare Research and Quality (AHRQ) Procalcitonin-guided antibiotic therapy
2012     National Institute for Health and Care Excellence (NICE) Ivabradine for treating chronic heart failure. NICE technology appraisal guidance 267
2012     National Institute for Health and Care Excellence (NICE) Radiofrequency cold ablation for respiratory papillomatosis. NICE interventional procedures guidance 434
2012     HAYES, Inc. Hysteroscopic morcellation (Truclear Morcellator System; Smith & Nephew Inc.) for treatment of uterine submucosal fibroids and endometrial polyps
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Opioid management practices for the prevention of drug diversion and misuse: a review of the clinical evidence and guidelines
2012     NIHR Horizon Scanning Centre (NIHR HSC) Spartan RX™ point-of-care DNA test for identifying the CYP2C19*2 mutation
2012     Agency for Healthcare Research and Quality (AHRQ) Physical therapy interventions for knee pain secondary to osteoarthritis
2012     National Institute for Health and Care Excellence (NICE) Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma. NICE technology appraisal guidance 268
2012     National Institute for Health and Care Excellence (NICE) Endovascular stent insertion for intracranial atherosclerotic disease. NICE interventional procedures guidance 429
2012     Agency for Healthcare Research and Quality (AHRQ) Reliability testing of the AHRQ EPC approach to grading the strength of evidence in comparative effectiveness reviews
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Abuse and misuse potential of pregabalin: a review of the clinical evidence
2012     NIHR Horizon Scanning Centre (NIHR HSC) Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO®) impulse system for acute coronary syndromes including heart attack
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Hyperthermia in breast-, bladder-, cervix carcinoma and soft tissue sarcoma patients
2012     Agency for Healthcare Research and Quality (AHRQ) Treatment for hepatitis C virus infection in adults
2012     National Institute for Health and Care Excellence (NICE) Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma. NICE technology appraisal guidance 269
2012     National Institute for Health and Care Excellence (NICE) Partial replacement of the meniscus of the knee using a biodegradable scaffold. NICE interventional procedures guidance 430
2012     NIHR Horizon Scanning Centre (NIHR HSC) Clofarabine (Evoltra) for acute myeloid leukaemia in older adults unsuitable for anthracycline-based combination chemotherapy
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Newborn screening for cystic fibrosis: a review of the clinical and cost-effectiveness
2012     NIHR Horizon Scanning Centre (NIHR HSC) SCOUT DS® and Diab-spot for type 2 diabetes screening
2012     Agency for Healthcare Research and Quality (AHRQ) Progestogens for prevention of preterm birth
2012     National Institute for Health and Care Excellence (NICE) Decitabine for the treatment of acute myeloid leukaemia (terminated appraisal). NICE technology appraisal guidance 270
2012     National Institute for Health and Care Excellence (NICE) Percutaneous balloon cryoablation for pulmonary vein isolation in atrial fibrillation. NICE interventional procedures guidance 427
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Periostat for periodontal disease: a review of the clinical effectiveness, cost effectiveness and guidelines
2012     NIHR Horizon Scanning Centre (NIHR HSC) Faldaprevir with BI 207127 for chronic hepatitis C infection, genotype 1
2012     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Efficacy and safety of ornithine in treating hyperammonemia from acute and chronic liver diseases]
2012     Agency for Healthcare Research and Quality (AHRQ) Screening for hepatitis C virus infection in adults
2012     National Institute for Health and Care Excellence (NICE) Focal therapy using cryoablation for localised prostate cancer. NICE interventional procedures guidance 423
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacologic smoking cessation interventions for patients with cardiovascular conditions: a review of the safety and guidelines
2012     NIHR Horizon Scanning Centre (NIHR HSC) Secukinumab for active and progressive psoriatic arthritis
2012     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Efficacy and safety of the artificial urinary sphincter (AS) in treating postprostatectomy urinary incontinence]
2012     Agency for Healthcare Research and Quality (AHRQ) Screening, behavioral counseling, and referral in primary care to reduce alcohol misuse
2012     National Institute for Health and Care Excellence (NICE) Micropressure therapy for refractory Ménière's disease. NICE interventional procedures guidance 426
2012     NIHR Health Technology Assessment programme A pilot randomised controlled trial in intensive care patients comparing 7 days' treatment with empirical antibiotics with 2 days' treatment for hospital-acquired infection of unknown origin
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Watchful dosing of morphine or morphine equivalent dosing in the treatment of chronic non-cancer pain: a review of the clinical evidence
2012     NIHR Horizon Scanning Centre (NIHR HSC) Secukinumab for ankylosing spondylitis – second line
2012     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Efficacy and safety of tocilizumab in treating rheumatoid arthritis]
2012     Agency for Healthcare Research and Quality (AHRQ) First-generation versus second-generation antipsychotics in adults: comparative effectiveness.
2012     National Institute for Health and Care Excellence (NICE) Incisionless otoplasty. NICE interventional procedures guidance 422
2012     NIHR Health Technology Assessment programme Abiraterone acetate for the treatment of metastatic, castrate-resistant prostate cancer following previous cytotoxic chemotherapy
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Opioid trial periods for management of chronic non-cancer pain: a review of clinical effectiveness, guidelines and recommendations
2012     NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: Alair® bronchial thermoplasty system for severe asthma
2012     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Uterine artery embolization in patients aiming to preserve the uterus]
2012     Agency for Healthcare Research and Quality (AHRQ) Drug therapy for rheumatoid arthritis in adults: an update.
2012     National Institute for Health and Care Excellence (NICE) Breast reconstruction using lipomodelling after breast cancer treatment. NICE interventional procedures guidance 417
2012     NIHR Health Technology Assessment programme Botulinum toxin type A for the prophylaxis of headaches in adults with chronic migraine
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Dental treatment to correct dental caries in patients undergoing surgery: a review of clinical evidence on safety
2012     NIHR Horizon Scanning Centre (NIHR HSC) Tofacitinib for moderate to severe chronic plaque psoriasis – second line
2012     HAYES, Inc. Orthotic compression bracing for treatment of pectus carinatum
2012     Agency for Healthcare Research and Quality (AHRQ) Drug therapy for psoriatic arthritis in adults: update of a 2007 report.
2012     New Zealand National Health Committee (NHC) Catheter ablation for the treatment of atrial fibrillation - technology note
2012     NIHR Health Technology Assessment programme Erlotinib for the first-line treatment of EGFR-TK mutation positive non-small-cell lung cancer
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Chlorhexidine gluconate (CHG) for suturing in the emergency room and perineal washing during vaginal deliveries: a review of safety, evidence-based guidelines and recommendations
2012     NIHR Horizon Scanning Centre (NIHR HSC) ICX-RHY (Vavelta) for recessive dystrophic epidermolysis bullosa –second line
2012     HAYES, Inc. Percutaneous epidural adhesiolysis for chronic back pain
2012     Agency for Healthcare Research and Quality (AHRQ) Dietary supplements in adults taking cardiovascular drugs
2012     New Zealand National Health Committee (NHC) Problem-solving therapy (PST) for people who present to hospital with self-harm - technology note
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Dental x-rays and cancer: a review of the evidence on safety
2012     HAYES, Inc. Percutaneous needle aponeurotomy for Dupuytren contracture
2012     Agency for Healthcare Research and Quality (AHRQ) Chronic kidney disease stages 1–3: screening, monitoring, and treatment.
2012     New Zealand National Health Committee (NHC) Transcatheter Aortic Valve Implantation (TAVI) - briefing report
2012     NIHR Health Technology Assessment programme Rivaroxaban for the treatment of deep vein thrombosis and secondary prevention of venous thromboembolism
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Composite resin and amalgam dental filling materials: a review of safety, clinical effectiveness and cost-effectiveness
2012     HAYES, Inc. Pipeline embolization device (Covidien ev3) for treatment of intracranial aneurysms
2012     NIHR Health Technology Assessment programme Ruxolitinib for the treatment of myelofibrosis
2012     HAYES, Inc. Phototherapy for early-stage mycosis fungoides
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy for adult psychiatric inpatients: a review of clinical evidence and effectiveness
2012     HAYES, Inc. Plasmapheresis for hypertriglyceridemia-induced pancreatitis
2012     NIHR Health Technology Assessment programme Eltrombopag for the treatment of chronic immune thrombocytopenic purpura (ITP): a single technology appraisal
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Clopidogrel, prasugrel and ticagrelor in adults with acute coronary syndrome: a review of the clinical effectiveness, cost effectiveness and guidelines
2012     HAYES, Inc. Provent sleep apnea therapy (Ventus Medical Inc.)
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Neurofeedback and biofeedback for post-traumatic stress disorder, generalized anxiety disorder, and depression: a review of the clinical evidence and guidelines.
2012     HAYES, Inc. P-Stim (Biegler GmbH) auricular electroacupuncture for pain management
2012     National Evidence-based Healthcare Collaborating Agency (NECA) [Management and improvement in cancer pain: focusing on narcotic analgesics]
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Negative pressure wound therapy for patients with diabetic foot ulcers and pressure ulcers: a review of the clinical effectiveness
2012     National Evidence-based Healthcare Collaborating Agency (NECA) [Comparative effectiveness study of catheter ablation for atrial fibrillation]
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Custom foot orthotics for adults with foot conditions: a review of the clinical and cost effectiveness
2012     National Evidence-based Healthcare Collaborating Agency (NECA) [Clinically relevant venous thromboembolism following hip and knee arthroplasty]